Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
1.835
-0.005 (-0.27%)
Apr 17, 2025, 4:00 PM EDT - Market closed

Heron Therapeutics Market Cap

Heron Therapeutics has a market cap or net worth of $280.29 million as of April 17, 2025. Its market cap has decreased by -27.44% in one year.

Market Cap
280.29M
Enterprise Value
398.77M
1-Year Change
-27.44%
Ranking
Category
Stock Price
$1.84

Market Cap Chart

Since December 1, 1998, Heron Therapeutics's market cap has increased from $127.40M to $280.29M, an increase of 120.01%. That is a compound annual growth rate of 3.03%.

History

DateMarket Cap% Change
Apr 17, 2025280.30M20.46%
Dec 31, 2024232.70M-8.78%
Dec 29, 2023255.10M-14.17%
Dec 30, 2022297.20M-68.07%
Dec 31, 2021930.70M-51.60%
Dec 31, 20201.92B-9.13%
Dec 31, 20192.12B4.57%
Dec 31, 20182.02B105.15%
Dec 29, 2017986.50M92.15%
Dec 30, 2016513.40M-46.54%
Dec 31, 2015960.40M227.11%
Dec 31, 2014293.60M110.32%
Dec 31, 2013139.60M-15.24%
Dec 31, 2012164.70M258.04%
Dec 30, 201146.00M154.14%
Dec 31, 201018.10M-63.51%
Dec 31, 200949.60M281.54%
Dec 31, 200813.00M-73.25%
Dec 31, 200748.60M39.66%
Dec 29, 200634.80M-10.08%
Dec 30, 200538.70M-6.30%
Dec 31, 200441.30M-18.22%
Dec 31, 200350.50M146.34%
Dec 31, 200220.50M-63.91%
Dec 31, 200156.80M18.33%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 758.41B
UnitedHealth Group 432.28B
Johnson & Johnson 377.64B
AbbVie 306.56B
Novo Nordisk 284.50B
Abbott Laboratories 227.06B
AstraZeneca 210.38B
Novartis AG 210.23B
Market Cap Rankings